Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Extrapyramidal symptoms due to dopamine-blocking agents in patients with AIDS encephalopathy.

Hriso E, Kuhn T, Masdeu JC, Grundman M.

Am J Psychiatry. 1991 Nov;148(11):1558-61.

PMID:
1681751
2.
3.

Incidence of extrapyramidal syndromes in AIDS patients and a comparison group of medically ill inpatients.

Ramachandran G, Glickman L, Levenson J, Rao C.

J Neuropsychiatry Clin Neurosci. 1997 Fall;9(4):579-83.

PMID:
9447500
4.

A comparison of antipsychotic drug-defined daily doses versus chlorpromazine equivalent doses in patients with or without extrapyramidal motor symptoms.

Barr AM, Honer WG, Johnson JL, Wu TK, Procyshyn RM.

J Clin Psychopharmacol. 2010 Dec;30(6):741-3. doi: 10.1097/JCP.0b013e3181fab7ca. No abstract available.

PMID:
21057241
5.

The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapine, risperidone, and conventional antipsychotics.

Miller CH, Mohr F, Umbricht D, Woerner M, Fleischhacker WW, Lieberman JA.

J Clin Psychiatry. 1998 Feb;59(2):69-75.

PMID:
9501888
6.

Neuroleptic drug exposure and treatment of parkinsonism in the elderly: a case-control study.

Avorn J, Bohn RL, Mogun H, Gurwitz JH, Monane M, Everitt D, Walker A.

Am J Med. 1995 Jul;99(1):48-54.

PMID:
7598142
7.

Anticholinergic agents for prophylaxis of neuroleptic-induced dystonic reactions: a prospective study.

Sramek JJ, Simpson GM, Morrison RL, Heiser JF.

J Clin Psychiatry. 1986 Jun;47(6):305-9.

PMID:
2872206
8.

Attenuation of neuroleptic-induced extrapyramidal side effects by Kava special extract WS 1490.

Boerner RJ, Klement S.

Wien Med Wochenschr. 2004 Nov;154(21-22):508-10.

PMID:
15638068
9.

Assessment of extrapyramidal symptoms during acute neuroleptic treatment.

Mazure CM, Cellar JS, Bowers MB Jr, Nelson JC, Takeshita J, Zigun B.

J Clin Psychiatry. 1995 Mar;56(3):94-100.

PMID:
7883736
10.

Acute extrapyramidal syndromes in neuroleptic-treated elders: a pilot study.

Ganzini L, Heintz R, Hoffman WF, Keepers GA, Casey DE.

J Geriatr Psychiatry Neurol. 1991 Oct-Dec;4(4):222-5.

PMID:
1686396
11.

Extrapyramidal side effects: a historical perspective.

Rifkin A.

J Clin Psychiatry. 1987 Sep;48 Suppl:3-6.

PMID:
2887555
12.

[Extrapyramidal movement disorders arising during treatment of psychoses with drugs].

Vatsek Ia.

Zh Nevropatol Psikhiatr Im S S Korsakova. 1976;76(3):453-7. Review. Russian. No abstract available.

PMID:
4940
13.
14.

Antipsychotic prescribing patterns and the treatment of extrapyramidal symptoms in older people.

Kalish SC, Bohn RL, Mogun H, Glynn RJ, Gurwitz JH, Avorn J.

J Am Geriatr Soc. 1995 Sep;43(9):967-73.

PMID:
7657936
15.

[Dysphagia or dysphagias during neuroleptic medication?].

Chaumartin N, Monville M, Lachaux B.

Encephale. 2012 Sep;38(4):351-5. doi: 10.1016/j.encep.2011.07.002. Epub 2011 Oct 11. French.

PMID:
22980477
16.

[Extrapyramidal effects of antipsychotic drugs].

Kulisevsky J, Otermin P.

Neurologia. 2003 Jun;18(5):262-8. Review. Spanish.

PMID:
12768512
17.

Psychosis in elderly patients: classification and pharmacotherapy.

Mintzer J, Targum SD.

J Geriatr Psychiatry Neurol. 2003 Dec;16(4):199-206. Review.

PMID:
14653427
18.

The impact of neuroleptic dosage and extrapyramidal side effects on schizophrenic basic symptoms.

Moritz S, Krausz M, Gottwalz E, Andresen B.

Compr Psychiatry. 2000 Jul-Aug;41(4):284-8.

PMID:
10929797
19.

Extrapyramidal symptoms and oestrogen.

Thompson KN, Kulkarni J, Sergejew AA.

Acta Psychiatr Scand. 2000 Feb;101(2):130-4.

PMID:
10706013
20.

Rapid shifts in therapeutic and extrapyramidal effects of neuroleptics.

McEvoy JP.

Am J Psychiatry. 1986 Nov;143(11):1504. No abstract available.

PMID:
2877588

Supplemental Content

Support Center